Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Unveiling the comorbidity hub: WT1 drives renal cancer progression in chronic kidney disease and confers sirolimus vulnerability (2026-06-19)
Journal: Experimental and Therapeutic Medicine (2026) IF: 2.2Products Cited: Fetal Bovine Serum, DMEM (High glucose) Medium -
LINC00473 modulates protein expression to promote ovarian cancer progression and overcome cisplatin resistance (2026-01-12)
Journal: Oncology Letters (2026) IF: 2.2 -
Pro?tumourigenic effects of DCAF13 on the progression of colorectal cancer (2026-02-25)
Journal: Oncology Letters (2026) IF: 2.2Products Cited: MEM, with NEAA, DMEM (High glucose) Medium -
Leucovorin enhances curcumin?induced inhibition of cell viability and ferroptosis in colorectal cancer cells (2026-03-04)
Journal: Oncology Letters (2026) IF: 2.2Products Cited: Fetal Bovine Serum -
RNA methyltransferase NSUN2 enhances vasculogenic mimicry and malignant progression of cervical cancer through upregulation of MMP?9 (2026-03-06)
-
Pomegranate peel?derived exosome?like nanoparticles: A discarded treasure trove for colorectal cancer treatment (2026-03-26)
-
Lung squamous cell carcinoma downregulates haptoglobin expression to inhibit M2 macrophage ferroptosis via the hemoglobin?dependent CD163/HO?1 pathway (2026-03-30)
-
Exosomal?miR?32?5p directly targets FOXN2 to regulate the proliferation, migration and apoptosis of uterine corpus endometrial carcinoma via the PI3K/AKT/BCL?2 pathway (2026-04-08)
-
Overexpression and knockdown of 5?lipoxygenase regulates the migration and invasion of colorectal cancer cells (2026-04-08)
Journal: Oncology Letters (2026) IF: 2.2 -
Machine learning?based programmed cell death gene signature for prognosis and drug sensitivity in breast cancer (2026-04-08)
Journal: Oncology Letters (2026) IF: 2.2
